On Tuesday, Danaher Corporation (NYSE:DHR)’s shares declined -0.98% to $85.57.
Danaher Corporation (DHR) declared that its Board of Directors has approved a regular quarterly dividend of $0.135 per share payable on October 30, 2015 to holders of record on September 25, 2015.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company’s Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; hardware and software solutions to deploy, manage, and secure communication network technologies and services; and tools, toolboxes, and automotive maintenance equipment.
Unilever N.V. (ADR) (NYSE:UN)’s shares dropped -2.82% to $39.01.
Unilever has been named as a leader of the Food, Beverage and Tobacco Industry Group in the 2015 Dow Jones Sustainability Index (DJSI) results. It is one of only 24 companies to be named as Industry Group Leaders.
Unilever achieved an overall score of 92 out of a possible 100, an enhance from 90 in 2014.
Unilever led, or jointly led, the industry in eight of the 23 Food Products criteria, counting: Innovation Administration; Strategy for Emerging Markets; Climate Strategy; Packaging; and Talent Attraction & Retention.
The DJSI is a globally recognized independent benchmark that measures proven company performance across material economic, environmental and social criteria. Unilever has been a member of the DJSI World Index since it began in 1999.
Unilever N.V. operates as a fast-moving consumer goods company in the Americas, Europe, Asia, Australasia, Africa, the Middle East, Turkey, Russia, Ukraine, and Belarus. The company operates through Personal Care, Foods, Refreshment, and Home Care segments. The Personal Care segment offers skincare and haircare products, deodorants, and oral care products.
At the end of Tuesday’s trade, Boeing Co (NYSE:BA)‘s shares dipped -1.49% to $133.99.
Boeing [NYSE: BA] declared that 747 fuselage panels will be built at its Macon, Georgia facility starting in 2018.
Boeing will take over the work from Triumph Aerostructures – Vought Aircraft Division, a wholly owned partner of Triumph Group, Inc., with the Macon site providing assembled fuselage panels to Boeing’s 747 final assembly line in Everett, Washington. Boeing and Triumph Aerostructures have worked together to ensure a smooth transition for the 747 supply chain.
Boeing and Triumph Aerostructures have worked together for many months to ensure a smooth transition for the 747 supply chain. As part of this detailed process, the Boeing team selected the Boeing Defense, Space & Security Macon facility for 747 fuselage panel work.
Defense work presently performed at the Macon site comprises replacement center wing sections for the A-10 Thunderbolt II, in addition to sub-assemblies for the CH-47 Chinook helicopter. Fuselage panels for the C-17 Globemaster transport airplane were also produced at the site until earlier this year.
The Boeing Company, together with its auxiliaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide. The company operates in five segments: Commercial Airplanes, Boeing Military Aircraft, Network & Space Systems, Global Services & Support, and Boeing Capital.
Cardinal Health Inc (NYSE:CAH), ended its Tuesday’s trading session with -1.82% loss, and closed at $81.49.
Cardinal Health, which provides medical products and services to many of America’s most prestigious medical institutions, recently declared the launch of the Hospital Quality at Home™ brand, a new line of hospital-quality products accessible over the counter to assist loved ones and caregivers transition care from the hospital to home. The product line provides a full assortment of hospital-quality products for consumers categorized as Advanced Wound Care, First Aid, Personal Care, and Home Healthcare which assist provide comfort and independence, while assisting to promote healing.
When leaving the hospital after childbirth, injury or surgery, the care you provide for yourself or a loved one is important. Each year, hospitals discharge 35.1 million patients1 with 65 percent of those discharged to the home setting for care.2 Effective post-hospital care is critical to avoid re-admission as one in five patients are readmitted within 30 days of discharge.2 With rising health care costs3 the Hospital Quality at Home™ line of products can provide patients, loved ones, and caregivers effective and cost-efficient ways to manage care at home.
Cardinal Health, Inc. operates as a healthcare services and products company worldwide. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, counting chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
